NOT KNOWN FACTUAL STATEMENTS ABOUT PHARMA EXCIPIENTS

“The current situation has exposed some structural weaknesses inside the EU’s medicines source chain as well as a high dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides claimed. She suggested that supply chain concerns be resolved in an EU pharmaceutical method expected to become launched by the